# US 2023/0159450 A1 · Dimers for use in synthesis of peptidomimetics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0159450 A1
- Document ID: US20230159450A1
- Status: Published application
- Kind: A1
- Application number: 17/922,945
- Filed: 2021-05-07
- Published: 2023-05-25
- Earliest claimed: 2020-05-08
- Assignees: The Feinstein Institutes for Medical Research
- Applicants: The Feinstein Institutes for Medical Research
- Inventors: Yousef Al-Abed; Ahmad Altiti
- Web page: https://patentgrep.com/patent/US20230159450A1

## CPC

- C07C 333/12: having nitrogen atoms of thiocarbamic groups bound to other hetero atoms
- C07D 207/16: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 231/04: having no double bonds between ring members or between ring members and non-ring members
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Dimers for use in synthesis of peptidomimetics are described. Uses of dimers as synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the dimers and uses of azapeptides and other peptidomimetics are also described.

## Claims

### Claim 1

A compound of Formula (I):
and salts thereof, wherein
A is N-phthalimidyl or NR3R4, wherein (i) R3 is H and R4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonyl or (ii) R3 and R1 are connected and together form a side chain radical of proline and R4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonyl;
A1 is H or absent;
A2 is H or absent;
X is selected from the group consisting of imidazolyl, benzotriazolyl, S-D, and O-L;
D is H, Cl, an alkyl, an aryl or a heteroaryl;
L is an alkyl, imidazolyl or benzotriazolyl;
R1 and R2 is each independently selected from the group consisting of side chain radicals of amino acids;
Z1 and Z2 is each independently C or N.

### Claim 2 (depends on 1)

A compound according to claim 1, wherein at least one of Z1 and Z2 is N.

### Claim 3

A compound of Formula (IA):
and salts thereof, wherein
A is N-phthalimidyl or NR3R4, wherein (i) R3 is H and R4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonyl or (ii) R3 and R1 are connected and together form a side chain radical of proline and R4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonyl;
A1 is H or absent;
X is selected from the group consisting of imidazolyl, benzotriazolyl, S-D and O-L;
D is H, Cl, an alkyl, an aryl or a heteroaryl;
L is an alkyl, imidazolyl or benzotriazolyl;
R1 is selected from the group consisting of side chain radicals of amino acids;
Z1 is C or N.

### Claim 4

A compound of Formula (VII):
and salts thereof, wherein
A is N-phthalimidyl or NR3R4, wherein (i) R3 is H and R4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, or 2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonyl, or (ii) R3 and R1 are connected and together form a side chain radical of proline and R4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, or 2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonyl;
A1 is hydrogen or absent;
A2 is hydrogen or absent;
K is a halogen;
R1 and R2 is each independently selected from the group consisting of side chain radicals of amino acids;
Z1 and Z2 is each independently C or N.

### Claim 5 (depends on 1)

A compound according to claim 1, wherein A is NR3R4, wherein R3 is H and R4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, 2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonyl.

### Claim 6 (depends on 1)

A compound according to claim 1, wherein A is N-phthalimidyl.

### Claim 7 (depends on 1)

A compound according to claim 1, wherein A is NR3R4, R3 is H, R4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, 2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonyl, and R3 and R1 are connected and together form a side chain radical of proline.

### Claim 8 (depends on 1)

A compound according to claim 1, wherein X is selected from the group consisting of imidazolyl and benzotriazolyl.

### Claim 9 (depends on 1)

A compound according to claim 1, wherein X is S-D; and D is an alkyl.

### Claim 10 (depends on 9)

A compound according to claim 9, wherein the alkyl is ethyl.

### Claim 11 (depends on 1)

A compound according to claim 1, wherein X is O-L; and L is imidazolyl or benzotriazolyl.

### Claim 12 (depends on 11)

A compound according to claim 11, wherein L is benzotriazolyl.

### Claim 13 (depends on 1)

A compound according to claim 1, wherein Z1 and Z2 are both N.

### Claim 14 (depends on 1)

A compound according to claim 1, wherein Z1 and Z2 are both C.

### Claim 15 (depends on 1)

A compound according to claim 1, for use in a liquid phase synthesis of an azapeptide.
